Guerrero-Ochoa, P.; Rodríguez-Zapater, S.; Anel, A.; Esteban, L.M.; Camón-Fernández, A.; Espilez-Ortiz, R.; Gil-Sanz, M.J.; Borque-Fernando, Á.
Prostate Cancer and the Mevalonate Pathway. Int. J. Mol. Sci. 2024, 25, 2152.
https://doi.org/10.3390/ijms25042152
AMA Style
Guerrero-Ochoa P, Rodríguez-Zapater S, Anel A, Esteban LM, Camón-Fernández A, Espilez-Ortiz R, Gil-Sanz MJ, Borque-Fernando Á.
Prostate Cancer and the Mevalonate Pathway. International Journal of Molecular Sciences. 2024; 25(4):2152.
https://doi.org/10.3390/ijms25042152
Chicago/Turabian Style
Guerrero-Ochoa, Patricia, Sergio Rodríguez-Zapater, Alberto Anel, Luis Mariano Esteban, Alejandro Camón-Fernández, Raquel Espilez-Ortiz, María Jesús Gil-Sanz, and Ángel Borque-Fernando.
2024. "Prostate Cancer and the Mevalonate Pathway" International Journal of Molecular Sciences 25, no. 4: 2152.
https://doi.org/10.3390/ijms25042152
APA Style
Guerrero-Ochoa, P., Rodríguez-Zapater, S., Anel, A., Esteban, L. M., Camón-Fernández, A., Espilez-Ortiz, R., Gil-Sanz, M. J., & Borque-Fernando, Á.
(2024). Prostate Cancer and the Mevalonate Pathway. International Journal of Molecular Sciences, 25(4), 2152.
https://doi.org/10.3390/ijms25042152